Apimeds Pharmaceuticals US, Inc. (APUS)
1.70
+0.02
(+1.19%)
USD |
NYAM |
Jan 21, 11:16
Apimeds Pharmaceuticals US Market Cap: 21.58M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 697.74M |
| Palatin Technologies, Inc. | 15.80M |
| Theriva Biologics, Inc. | 6.519M |
| Oragenics, Inc. | 0.7817M |
| NanoViricides, Inc. | 21.42M |
Market Cap Related Metrics
| PEG Ratio | -0.017 |
| Price to Book Value | 2.644 |
| Price | 1.70 |
| Earnings Yield | -25.34% |
| PEGY Ratio | -0.017 |